Rockwell Med Inc SEC Filings

Autodesk, Inc. (ADSK) – Form 144 Filing Overview

On July 3, 2025, Autodesk filed a Form 144 indicating a proposed insider sale of company stock under Rule 144 of the Securities Act. The filing covers a planned disposition by insider Rebecca Pearce involving 3,251 shares of Autodesk common stock, to be executed through Morgan Stanley Smith Barney LLC on the NASDAQ exchange. The aggregate market value of the proposed sale is listed at $1,024,065. For context, Autodesk has approximately 214 million shares outstanding, making the contemplated sale roughly 0.0015 % of total shares.

The filing also discloses prior insider activity during the three-month look-back period. Between June 17 – 30, 2025, Pearce sold a cumulative 6,140 shares for gross proceeds of about $1.89 million. The proposed July trade would lift her total disclosed dispositions over the four-month span to 9,391 shares, with combined proceeds approximating $2.9 million.

Share acquisition background

• 1,341 shares originated from restricted stock granted on March 26, 2024.
• 1,910 shares stem from performance shares granted on March 27, 2025.

No indication is given that the shares were gifts, and payment details are marked “Not Applicable,” implying the shares were granted as equity compensation.

Materiality assessment

• While insider sales can raise sentiment concerns, the volume is immaterial relative to Autodesk’s float.
• The filing does not cite any undisclosed adverse information, and the signer affirms compliance with Rule 10b5-1, which may mitigate interpretation of the sale as a negative signal.

Rockwell Medical, Inc. (RMTI) – Form 4/A amendment reports that Senior Vice President & Chief Financial Officer Jesse Neri sold 886 common shares on 01-Jul-2025 at a weighted-average price of $0.82 per share. The filing clarifies that the trade was executed pursuant to a Rule 10b5-1 trading plan adopted on 13-Dec-2024; this checkbox was inadvertently left blank in the original Form 4 filed 02-Jul-2025.

After the disposition, Neri directly owns 126,614 shares of RMTI. No derivative securities were bought or sold, and there are no other changes to his ownership stake.

The transaction represents roughly 0.7 % of the executive’s reported holdings and is immaterial relative to the company’s total shares outstanding. Because the sale was pre-arranged and the amendment is purely administrative, the filing carries limited fundamental significance but may still interest investors who monitor insider activity for sentiment cues.

Enhabit, Inc. (EHAB) – Form 4 insider transaction

Chief Human Resources Officer Tanya Renee Marion reported a single transaction dated 1 July 2025. Under transaction code F (shares withheld by the issuer to satisfy tax obligations upon vesting), 1,983 common shares were disposed of at an average price of $7.88 per share. Following the withholding, the executive’s direct beneficial ownership stands at 57,651 common shares. No derivative securities were reported, and the filing was signed on 2 July 2025.

The transaction represents routine tax-related share withholding rather than an open-market sale, so it does not materially alter the insider’s economic exposure or signal a change in conviction. The filing meets Section 16 reporting requirements and contains no additional commentary or unusual provisions.

Dropbox, Inc. (ticker: DBX) filed a Form 4 on 2 July 2025 reporting two open-market sales of Class A common stock by Chief Financial Officer Timothy Regan.

• Transaction dates & volumes: 2,500 shares sold on 30 Jun 2025 at $28.40; 10,000 shares sold on 1 Jul 2025 at a weighted-average $27.9392.
• Total shares sold: 12,500, representing approximately 2.4 % of the executive’s post-sale holdings.
• Remaining ownership: 516,094 Class A shares held directly.
• Trading plan: All sales executed under a Rule 10b5-1 plan adopted on 15 May 2024, indicating pre-arranged, schedule-based transactions.
• Equity mix: Remaining position includes restricted stock awards/units that vest through 15 Feb 2029; any unvested awards cancel if employment ends.

The filing discloses no derivative transactions and contains no indication of additional insider participation. While insider sales can be perceived negatively, the modest size relative to Regan’s continuing stake and the existence of a 10b5-1 plan mitigate potential signaling risk. No operational or financial performance metrics were provided in this document.

Form 4 snapshot: On 06/30/2025, director John H. C. Pinsent received 8,440 Class A Ordinary Shares of New Horizon Aircraft Ltd. (HOVR) through a transaction coded “A,” indicating a cost-free grant/award rather than an open-market purchase. The filing reports a price of $0.00 per share.

After the grant, Pinsent’s direct holding rises to 56,654 shares. No derivative securities were acquired or disposed of, and there were no other insider participants in this filing.

Because the award is modest relative to likely shares outstanding and was not made with personal capital, market impact should be minimal. Still, the incremental ownership marginally strengthens insider–shareholder alignment.

Rockwell Medical, Inc. (RMTI) filed a Form 144 indicating that 6,926 common shares may be sold under Rule 144. The proposed transaction will be executed through Raymond James & Associates on or after 1 July 2025.

The shares were acquired via RSU vesting on 17 March 2024. At the indicated aggregate market value of $5,536, the filing equates to roughly 0.02 % of the company’s 34.17 million shares outstanding; therefore, the sale is immaterial to share-count dilution and likely has negligible impact on liquidity.

The seller identified in the past-sales table is Mark Strobeck, who disposed of an identical 6,926-share block on 1 April 2025 for gross proceeds of $7,263. The current notice affirms that the filer is not aware of undisclosed material adverse information and is acting in compliance with SEC Rule 144 and related insider-trading provisions.

Overall, the filing represents routine insider portfolio management rather than a signal of fundamental change.

HSBC Holdings plc filed a Form 6-K detailing the latest execution under its US$3 bn share-buyback that commenced on 6 May 2025. On 1 July 2025 the bank repurchased 102,144 ordinary shares (par value US$0.50) on UK trading venues at a volume-weighted average price of £8.7047 (high £8.7360, low £8.6750). All shares were bought through Morgan Stanley & Co. International and will be cancelled.

Including this tranche, HSBC has now bought back 198,054,020 shares for an aggregate consideration of approximately US$2.31 bn. After cancellation, issued share capital will stand at 17,477,814,117 voting shares, with no shares held in treasury. A further notice will follow once Hong Kong-listed repurchases are cancelled.

The disclosure is made under UK MAR Article 5 and provides the denominator for shareholders’ DTR calculations. A breakdown of individual trades is available via the London Stock Exchange link provided.

• Shares repurchased 1 Jul 2025: 102,144
• VWAP: £8.7047
• Total buyback to date: 198.1 m shares | US$2.31 bn
• New share count: 17.48 bn

JPMorgan Chase Financial Company LLC is offering Auto Callable Accelerated Barrier Notes linked to the least-performing of the Dow Jones Industrial Average, the Nasdaq-100 Index and the Russell 2000 Index. The notes settle on or about July 11, 2025 with a scheduled maturity of July 13, 2028, unless automatically called.

• Automatic call feature: If the closing level of each index on the single Review Date (July 14, 2026) is at or above its Call Value (100 % of the initial level), investors receive $1,000 principal plus a Call Premium Amount of at least $157.50 (≥ 15.75 %) and the trade terminates one year early.
• Upside at maturity: If not called and the Final Level of each index exceeds its Initial Level, the return equals 1.5 × the performance of the worst index (Upside Leverage Factor 1.50), uncapped.
• Barrier protection: Principal is protected so long as the Final Level of each index remains at or above 70 % of its Initial Level (the Barrier Amount).
• Downside risk: If any index closes below the 70 % barrier on the Observation Date, investors lose 1 % of principal for every 1 % decline of the worst index; losses can reach 100 %.
• Credit exposure: The notes are senior unsecured obligations of JPMorgan Chase Financial, fully and unconditionally guaranteed by JPMorgan Chase & Co.; payments depend on both entities’ creditworthiness.
• Pricing economics: Estimated value today would be ≈ $944.40 per $1,000 note (minimum $920) versus a $1,000 offering price, reflecting distribution costs, hedging and funding spreads.
• Liquidity & income: Notes do not pay periodic interest, will not be listed on an exchange, and resale depends on the bid of J.P. Morgan Securities; investors forgo dividends on index constituents.

In sum, the structure offers leveraged, uncapped upside and a 15.75 % minimum call premium in year one, offset by significant downside and credit risk, limited liquidity, and an issue price that exceeds estimated fair value.